Alliance Medical Research

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Ulcerative colitis

Running trials

• Recruiting

  LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  NCT07186101· Phase 2· Eli Lilly and Company· Source

  Contact: Vipin Gupta (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ulcerative colitis1 recruiting